UPClytics
View all cases

UPC APP 9705/2024

EP1970677 · Intravenous infusion system with dosing device

Case details
Status
—
Action
Preliminary objection
Category
Preliminary objection
Parties
Claimants
Representatives
Respondents
Representatives
Division
Dusseldorf LD
Technology
  • Instruments
    Measurement · Medical technology
Language
—
First decided
Apr 11, 2024
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Dusseldorf LDLocked
Judge Berenice ThomLocked

At the UPC: Roche Group (29 cases)·VitalAire GmbH (11 cases)

This dispute contains 7 other proceedings

CC 21542/2024·UPC CFI 504/2023·UPC APP 11294/2025·UPC APP 23079/2025·UPC APP 28226/2025 and 2 more

1 other defendants litigating the same or a related patent

CC 20972/2024

Start a free trial to see how each one ended.

More cases: Dusseldorf LD·2024

Decisions
  • 2024-04-11
    Preliminary objectionPublic

    Summary: Düsseldorf Local Division dismissed preliminary objections concerning the language of proceedings in infringement case UPC_CFI_504/2023 (patent EP 1 970 677, glucose monitoring device). The court upheld German as the language of proceedings as chosen by claimant Roche, rejecting defendants' requests (VitalAire, Air Liquide Healthcare Nederland, Dinno Santé) to change the language to English. The defendants' preliminary objection was also ruled out of time due to a failure to deliver the objection papers to the Sub-Registry during its opening hours.

    Show the legal issues (3)
    • Language of proceedings under Rule 14.2 RoP and Art. 49 UPCA
    • Time limits for preliminary objections under Rule 4.2 RoP
    • Delivery of documents to Sub-Registry outside opening hours
Documents
  • EA3AA41EAB4A0D51F4A5AE97E7C26293_de.pdf2024-04-11DE